Chemoinformaics analysis of 9-Methoxycanthin-6-one N-oxide
| Molecular Weight | 266.256 | nRot | 1 |
| Heavy Atom Molecular Weight | 256.176 | nRig | 20 |
| Exact Molecular Weight | 266.069 | nRing | 4 |
| Solubility: LogS | -4.82 | nHRing | 3 |
| Solubility: LogP | 1.304 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 3 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 19 |
| nHA | 4 | APOL | 36.3239 |
| nHD | 0 | BPOL | 15.7841 |
| QED | 0.389 |
| Synth | 2.867 |
| Natural Product Likeliness | 0.585 |
| NR-PPAR-gamma | 0.026 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.002 |
| HIA | 0.006 |
| CACO-2 | -4.918 |
| MDCK | 0.0000326 |
| BBB | 0.407 |
| PPB | 0.835587 |
| VDSS | 0.878 |
| FU | 0.0598527 |
| CYP1A2-inh | 0.941 |
| CYP1A2-sub | 0.951 |
| CYP2c19-inh | 0.132 |
| CYP2c19-sub | 0.721 |
| CYP2c9-inh | 0.016 |
| CYP2c9-sub | 0.605 |
| CYP2d6-inh | 0.06 |
| CYP2d6-sub | 0.316 |
| CYP3a4-inh | 0.015 |
| CYP3a4-sub | 0.272 |
| CL | 8.516 |
| T12 | 0.667 |
| hERG | 0.083 |
| Ames | 0.983 |
| ROA | 0.066 |
| SkinSen | 0.076 |
| Carcinogencity | 0.977 |
| EI | 0.878 |
| Respiratory | 0.389 |
| NR-Aromatase | 0.038 |
| Antiviral | Yes |
| Prediction | 0.597125 |